PIK3CB and invasive ductal breast carcinoma: Genomic characterization studies have demonstrated that 18%–70% of ductal adenocarcinomas have genetic alterations related to the PI3K pathway6, 7, 8, 9; this is consistent with the frequency of alterations in this study (33.3%).